Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    cholangiocarcinoma AND gemox | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
Conditions: Cholangiocarcinoma of the Extrahepatic Bile Duct;   Gallbladder Cancer
Interventions: Procedure: biological test;   Drug: GEMOX;   Drug: Cetuximab;   Drug: Trastuzumab;   Drug: Gefitinib;   Drug: Lapatinib;   Drug: Everolimus;   Drug: Sorafenib;   Drug: Crizotinib
2 Recruiting Oxaliplatin+Gemcitabine vs Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma
Condition: Cholangiocarcinoma
Interventions: Drug: oxaliplatin and gemcitabine;   Drug: capecitabine

Study has passed its completion date and status has not been verified in more than two years.